JBC, Vol. 250, Issue 9, 3229-3235, May, 1975

Biochemical aspects of cardiac muscle differentiation. Deoxyribonucleic acid synthesis and nuclear and cytoplasmic deoxyribonucleic acid polymerase activity

W. C. Claycomb

DNA synthesis and DNA polymerase activity have been measured in terminally differentiating cardiac muscle of the rat. Incorporation of [3H]thymidine into DNA essentially ceases by the 17th day of postnatal development. Cardiac muscle of neonatal rats contains at least two molecular species of DNA polymerase: a 3.5 S DNA polymerase that can be extracted from nuclei with 0.2 m potassium phosphate and a 6 to 8 S soluble cytoplasmic DNA polymerase. The nuclear DNA polymerase in crude extracts has a pH optimum of 9.0 and is more active with native DNA than with denatured DNA as the primer-template. The cytoplasmic DNA polymerase in crude extracts has a pH optimum of 7.5 and is more active with denatured DNA. The activity of the 6 to 8 S cytoplasmic DNA polymerase decreases 80-fold from day 1 to day 17 after birth, which correlates temporally with the reduced rate of DNA synthesis. The activity of the 3.5 S nuclear DNA polymerase remains relatively constant throughout postnatal development. Mixing experiments (assay of neonatal enzyme extracts with adult enzyme extracts) gave additive results, suggesting that the decline in 6 to 8 S DNA polymerase activity apparently is not due to the presence of absence of soluble activators or inhibitors at different times during development. These studies may provide a system which can be used to investigate the control of DNA synthesis and cellular proliferation during the terminal stages of cardiac muscle differentiation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				R. Wadhawan, Y.-T. Tseng, J. Stabila, B. McGonnigal, S. Sarkar, and J. Padbury Regulation of cardiac beta 1-adrenergic receptor transcription during the developmental transition Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2146 - H2152. [Abstract] [Full Text] [PDF]

				T. Kakita, K. Hasegawa, T. Morimoto, S. Kaburagi, H. Wada, and S. Sasayama p300 Protein as a Coactivator of GATA-5 in the Transcription of Cardiac-restricted Atrial Natriuretic Factor Gene J. Biol. Chem., November 26, 1999; 274(48): 34096 - 34102. [Abstract] [Full Text] [PDF]

				F. B. Engel, L. Hauck, M. C. Cardoso, H. Leonhardt, R. Dietz, and R. von Harsdorf A Mammalian Myocardial Cell-Free System to Study Cell Cycle Reentry in Terminally Differentiated Cardiomyocytes Circ. Res., August 6, 1999; 85(3): 294 - 301. [Abstract] [Full Text] [PDF]

				T. Santalucia, K. R. Boheler, N. J. Brand, U. Sahye, C. Fandos, F. Vinals, J. Ferre, X. Testar, M. Palacin, and A. Zorzano Factors Involved in GLUT-1 Glucose Transporter Gene Transcription in Cardiac Muscle J. Biol. Chem., June 18, 1999; 274(25): 17626 - 17634. [Abstract] [Full Text] [PDF]

				K. Hasegawa, M. B. Meyers, and R. N. Kitsis Transcriptional Coactivator p300 Stimulates Cell Type-specific Gene Expression in Cardiac Myocytes J. Biol. Chem., August 8, 1997; 272(32): 20049 - 20054. [Abstract] [Full Text] [PDF]

				P. L. Kozlovskis, M. J.D. Smets, W. L. Strauss, and R. J. Myerburg DNA Synthesis in Adult Feline Ventricular Myocytes : Comparison of Hypoxic and Normoxic States Circ. Res., February 1, 1996; 78(2): 289 - 301. [Abstract] [Full Text]

				C. H. Van Meter Jr., W. C. Claycomb, J. B. Delcarpio, D. M. Smith, H. deGruiter, F. Smart, and J. L. Ochsner MYOBLAST TRANSPLANTATION IN THE PORCINE MODEL: A POTENTIAL TECHNIQUE FOR MYOCARDIAL REPAIR J. Thorac. Cardiovasc. Surg., November 1, 1995; 110(5): 1442 - 1448. [Abstract] [Full Text]

				J Bartolome, J Huguenard, and T. Slotkin Role of ornithine decarboxylase in cardiac growth and hypertrophy Science, November 14, 1980; 210(4471): 793 - 794. [Abstract] [PDF]